Details for Patent: 10,729,667
✉ Email this page to a colleague
Which drugs does patent 10,729,667 protect, and when does it expire?
Patent 10,729,667 protects NAFTIN and is included in one NDA.
This patent has three patent family members in three countries.
Summary for Patent: 10,729,667
Title: | Topical compositions and methods for making and using same |
Abstract: | The present invention relates to improved topical gel compositions comprising an active agent, and uses thereof. |
Inventor(s): | Hardas; Bhushan (Summerville, NC), Dalton; Donna (High Point, NC), Scheppler; Petra (Mainz, DE), Buch; Anja (Eschborn, DE), Boderke; Peter (Schwalbach, DE) |
Assignee: | |
Application Number: | 16/195,153 |
Patent Claim Types: see list of patent claims | Composition; Dosage form; |
Drugs Protected by US Patent 10,729,667
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sebela Ireland Ltd | NAFTIN | naftifine hydrochloride | GEL;TOPICAL | 204286-001 | Jun 27, 2013 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,729,667
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2014212201 | ⤷ Try a Trial | |||
Canada | 2899725 | ⤷ Try a Trial | |||
World Intellectual Property Organization (WIPO) | 2014121048 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |